Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life.

Maschio M, Dinapoli L, Sperati F, Fabi A, Pace A, Vidiri A, Muti P. Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life. J Neurooncol. 2012 Feb; 106(3):651-6.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.